Press

2019-08-23

Interim report for the second quarter 2019, 1 January – 30 June 2019

Second quarter in brief 1 April – 30 June 2019 Net sales for the period (January to June) amounted to SEK 3,1 Million (0 Million) of which the second quarter contributed SEK 0 Million (0 Million). R&D costs for...

Read More
2019-05-24

INTERIM REPORT FOR THE FIRST QUARTER 2019, 1 January – 31 March 2019

First quarter in brief 1 January – 31 March 2019 Net sales for the period (January to March) amounted to SEK 0.0 million (SEK 0.0 million) R&D costs for the period amounted to SEK 10,2 million (SEK 11,8 million)....

Read More
2019-03-06

Year End Report Kancera AB (publ) 1st January – 31st December 2018

This is a translation of the Year End Report in Swedish published February 20th 2019.

Read More
2018-11-23

INTERIM REPORT FOR KANCERA  AB (publ) 1st January – 30th September 2018

PERIOD JAN – SEPTEMBER 2018, AND THIRD QUARTER IN BRIEF • Net sales for the period (January to September) amounted to SEK 0.1 million (SEK 0.1 million) of which the third quarter amounted to SEK 0.1 million (SEK 0.0 million). • R&D...

Read More
2018-08-29

INTERIM REPORT FOR KANCERA  AB (publ) 1st January – 30th June 2018

PERIOD 1 JAN – 30 JUNE 2018 IN BRIEF • Net sales for the period amounted to MSEK 0.0 (0.1 million). Sales for the second quarter were 0.0 MEK (0.1 M) • R & D expenses for the period amounted to SEK 20.8...

Read More
2018-06-07

INTERIM REPORT FOR KANCERA  AB (publ) 1st January – 31st March 2018

PERIOD 1 JAN – 31 MARCH 2018 IN BRIEF • Net sales amounted to SEK 0 million (0 million) • R & D expenses amounted to SEK 11.8 million (8.3 M) • Operating profit amounted to SEK -12.5 million (-9.7 million) •...

Read More
2018-02-20

YEAR END REPORT KANCERA  AB (publ) 1st January – 31st December 2017

PERIOD 1 JAN – 31 DEC 2017 IN BRIEF • Net turnover for the period amounted to SEK 0.1 million (0.3 million). For the fourth quarter, turnover amounted to 0.0 MEK (0.1 M). • R & D expenses for the period amounted to...

Read More
2017-11-17

INTERIM REPORT FOR KANCERA  AB (publ) 1st January – 30th September 2017

PERIOD 1 JAN – 30 SEPT 2017 IN BRIEF • R&D expenses for the period amounted to SEK 39.8 million (13.3 million ), of which the third quarter amounted to SEK 14.7 million (4.6 million ) • Operating profit for the period amounted to...

Read More
2017-08-23

INTERIM REPORT FOR KANCERA  AB (publ) JANUARI 1ST – JUNE 30TH 2017

This is a translation from the original report published in Swedish August 22nd 2017.

Read More
2017-02-21

INTERIM REPORT FOR KANCERA AB (PUBL) Q4 2016. January 1st – December  31st 2016

THE PERIOD JANUARY – DECEMBER 2016 IN BRIEF R&D expenses for the period amounted to SEK 19,1M (SEK 20,4M) of which the fourth quarter constituted SEK 5.8M (SEK 8,3M). Operating income for the period amounted to SEK -22,3M (SEK -19.7M)...

Read More